ID: ALA111869

Max Phase: Preclinical

Molecular Formula: C18H20N2O2

Molecular Weight: 296.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CC(=O)N1c2ccccc2Oc2ccccc21

Standard InChI:  InChI=1S/C18H20N2O2/c1-3-19(4-2)13-18(21)20-14-9-5-7-11-16(14)22-17-12-8-6-10-15(17)20/h5-12H,3-4,13H2,1-2H3

Standard InChI Key:  HJULFWPABDXFGC-UHFFFAOYSA-N

Associated Targets(Human)

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

GC3/Cl 69 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 296.37Molecular Weight (Monoisotopic): 296.1525AlogP: 3.80#Rotatable Bonds: 4
Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.52CX LogP: 2.87CX LogD: 2.50
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.86Np Likeness Score: -0.78

References

1. Thimmaiah KN, Horton JK, Seshadri R, Israel M, Houghton JA, Harwood FC, Houghton PJ..  (1992)  Synthesis and chemical characterization of N-substituted phenoxazines directed toward reversing vinca alkaloid resistance in multidrug-resistant cancer cells.,  35  (18): [PMID:1527786] [10.1021/jm00096a009]

Source